monica slavin
monica slavin
PeterMacCallum Cancer and Royal Melbourne Hospital
Verified email at
Cited by
Cited by
Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group …
JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ...
Clinical Infectious Diseases 71 (6), 1367-1376, 2020
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group …
OA Cornely, A Alastruey-Izquierdo, D Arenz, SCA Chen, E Dannaoui, ...
The Lancet infectious diseases 19 (12), e405-e421, 2019
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation—a prospective, randomized, double-blind study
MA Slavin, B Osborne, R Adams, MJ Levenstein, HG Schoch, ...
Journal of Infectious Diseases 171 (6), 1545, 1995
The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports
W Jeong, C Keighley, R Wolfe, WL Lee, MA Slavin, DCM Kong, ...
Clinical microbiology and infection 25 (1), 26-34, 2019
Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of …
KA Marr, K Seidel, MA Slavin, RA Bowden, HG Schoch, MED Flowers, ...
Blood, The Journal of the American Society of Hematology 96 (6), 2055-2061, 2000
Combination antifungal therapy for invasive aspergillosis: a randomized trial
KA Marr, HT Schlamm, R Herbrecht, ST Rottinghaus, EJ Bow, OA Cornely, ...
Annals of internal medicine 162 (2), 81-89, 2015
Echinocandin antifungal drugs in fungal infections: a comparison
SCA Chen, MA Slavin, TC Sorrell
Drugs 71, 11-41, 2011
Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients
P Troke, K Aguirrebengoa, C Arteaga, D Ellis, CH Heath, I Lutsar, ...
Antimicrobial agents and chemotherapy 52 (5), 1743-1750, 2008
European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia
JA Maertens, C Girmenia, RJ Brüggemann, RF Duarte, CC Kibbler, ...
Journal of Antimicrobial Chemotherapy 73 (12), 3221-3230, 2018
Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised …
CO Morrissey, SCA Chen, TC Sorrell, S Milliken, PG Bardy, KF Bradstock, ...
The Lancet Infectious Diseases 13 (6), 519-528, 2013
Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience.
MA Slavin, JD Meyers, JS Remington, RC Hackman
Bone marrow transplantation 13 (5), 549-557, 1994
Active surveillance for candidemia, Australia
S Chen, M Slavin, Q Nguyen, D Marriott, EG Playford, D Ellis, T Sorrell
Emerging infectious diseases 12 (10), 1508, 2006
Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients
CC Blyth, SCA Chen, MA Slavin, C Serena, Q Nguyen, D Marriott, D Ellis, ...
Pediatrics 123 (5), 1360-1368, 2009
Successful Control of Disseminated Scedosporium prolificans Infection with a Combination of Voriconazole and Terbinafine
BP Howden, MA Slavin, AP Schwarer, AM Mijch
European Journal of Clinical Microbiology and Infectious Diseases 22, 111-113, 2003
Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab
KA Thursky, LJ Worth, JF Seymour, H Miles Prince, MA Slavin
British journal of haematology 132 (1), 3-12, 2006
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the …
M Hoenigl, J Salmanton-García, TJ Walsh, M Nucci, CF Neoh, JD Jenks, ...
The Lancet Infectious Diseases 21 (8), e246-e257, 2021
Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp
EG Playford, D Marriott, Q Nguyen, S Chen, D Ellis, M Slavin, TC Sorrell
Critical care medicine 36 (7), 2034, 2008
Clinical Manifestations of Cryptococcus gattii Infection: Determinants of Neurological Sequelae and Death
SCA Chen, MA Slavin, CH Heath, EG Playford, K Byth, D Marriott, SE Kidd, ...
Clinical infectious diseases 55 (6), 789-798, 2012
Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing
PL White, JR Wingard, S Bretagne, J Löffler, TF Patterson, MA Slavin, ...
Clinical Infectious Diseases 61 (8), 1293-1303, 2015
Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality
M Slavin, S Van Hal, TC Sorrell, A Lee, DJ Marriott, K Daveson, ...
Clinical Microbiology and Infection 21 (5), 490. e1-490. e10, 2015
The system can't perform the operation now. Try again later.
Articles 1–20